Literature DB >> 23105696

Circulating Immune complexes (CIC) as marker for disease progress in oral cancer.

Cynthia Jane1, A V Nerurkar, F R Karjodkar.   

Abstract

Oral Cancer is one of the five leading sites of cancer in Indian population. The circulating immune complexes were investigated in 100 serum samples of 60 oral cancer patients having different grades of the disease and 40 patients with precancerous lesions obtained from Nair Hospital Dental collage, Mumbai. The results obtained were compared with those of group of 40 healthy blood donors. Elevated levels of Circulating Immune Complexes were observed in oral cancer patients and patients with oral precancerous lesions. 92% positive samples were observed in well differentiated squamous cell carcinoma whereas 100% positive samples were observed in both moderately and poorly differentiated squamous cell carcinoma. Oral leukoplakia and oral submucous fibrosis showed 15% and 90% positivity respectively. Increased level of Circulating Immune complexes in high grade tumor suggest that Circulating Immune complexes is likely to contribute in evaluating the degree of malignancy, but follow up study is needed to draw any conclusion regarding it's prognostic role.

Entities:  

Keywords:  Circulating Immune complexes; Oral cancer; Oral leukoplakia; Oral submucous fibrosis; Squamous cell carcinoma

Year:  2007        PMID: 23105696      PMCID: PMC3453823          DOI: 10.1007/BF02913327

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  18 in total

1.  Oral cancer scene in India.

Authors:  P C Gupta; A Nandakumar
Journal:  Oral Dis       Date:  1999-01       Impact factor: 3.511

2.  Some naturally occurring and synthetic food components, furocoumarins and ultraviolet radiation. IARC Working Group. Lyon, 15-22 October 1985.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risk Chem Hum       Date:  1986

3.  Cell mediated and humoral immune responses in oral submucous fibrosis.

Authors:  R Rajendran; C K Sugathan; P Remani; R Ankathil; T Vijayakumar
Journal:  Cancer       Date:  1986-12-15       Impact factor: 6.860

4.  Tobacco habits other than smoking; betel-quid and areca-nut chewing; and some related nitrosamines. IARC Working Group. Lyon, 23-30 October 1984.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risk Chem Hum       Date:  1985-09

5.  Circulating immune complexes in Hodgkin's disease. Reactivity of IgG isolated from circulating immune complexes.

Authors:  A V Nerurkar; S H Advani; B P Gothoskar
Journal:  Neoplasma       Date:  1993       Impact factor: 2.575

6.  The use of polyethyleneglycol for immune complex detection in human sera.

Authors:  I Ríha; V Hasková; J Kaslík; M Maierová; J Stránský
Journal:  Mol Immunol       Date:  1979-07       Impact factor: 4.407

7.  Evaluation of cell-mediated immunity and circulating immune complexes as prognostic indicators in cancer patients.

Authors:  M Aziz; S Akhtar; A Malik
Journal:  Cancer Detect Prev       Date:  1998

8.  Circulating immune complexes and chemotherapy response in patients with head and neck cancer.

Authors:  B A Blazar; M P Fried; M Strome; J R Clark; P Sereno; S Rodliff; D Caminear
Journal:  Head Neck       Date:  1989 Sep-Oct       Impact factor: 3.147

9.  Oral submucous fibrosis in India: a new epidemic?

Authors:  P C Gupta; P N Sinor; R B Bhonsle; V S Pawar; H C Mehta
Journal:  Natl Med J India       Date:  1998 May-Jun       Impact factor: 0.537

10.  Tumor-associated antigen TA-90 immune complex assay predicts subclinical metastasis and survival for patients with early stage melanoma.

Authors:  M C Kelley; R C Jones; R K Gupta; R Yee; S Stern; L Wanek; D L Morton
Journal:  Cancer       Date:  1998-10-01       Impact factor: 6.860

View more
  2 in total

1.  Estimation of Circulating Immune Complexes in patients with Oral Leukoplakia and Oral Submucous Fibrosis: A Case Control Study.

Authors:  Maheswari H; Eswaran M A; Srividhya S; Malavika R; Prabhu R; Geetha K R
Journal:  J Clin Diagn Res       Date:  2014-01-12

2.  Clinical significance of circulating immune cells in left- and right-sided colon cancer.

Authors:  Jiabo Di; Meng Zhuang; Hong Yang; Beihai Jiang; Zaozao Wang; Xiangqian Su
Journal:  PeerJ       Date:  2017-12-08       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.